Buy now, pay later firm klarna files for ipo despite volatility

CITY

In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan

Wise had 9.8 million customers in the first quarter, up 17% year on year and 5% quarter-on-quarter

Out of puff: Second-quarter revenue at Connecticut-based Marlboro-maker Philip Morris International (PMI) rose 7.1% from a year earlier, to $10.1bn – slightly short of analysts’ expectations of $10.3b

Inflation raises it head: “With new higher [US] tariffs now in force for three months, there was one question that the June consumer price index [CPI] numbers needed to answer – ‘Are tariffs at last b

CITY